These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20445500)

  • 41. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG; Zhang F; Jin XL; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ΔFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488.
    Muschamp JW; Nemeth CL; Robison AJ; Nestler EJ; Carlezon WA
    Biol Psychiatry; 2012 Jan; 71(1):44-50. PubMed ID: 21962331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effects of processed Aconiti tuber on morphine-induced conditioned place preference in rats.
    Wu G; Huang W; Zhang H; Li Q; Zhou J; Shu H
    J Ethnopharmacol; 2011 Jun; 136(1):254-9. PubMed ID: 21549821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naltrexone and nalmefene attenuate cocaine place preference in male mice.
    Windisch KA; Reed B; Kreek MJ
    Neuropharmacology; 2018 Sep; 140():174-183. PubMed ID: 30048644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice.
    Skoubis PD; Lam HA; Shoblock J; Narayanan S; Maidment NT
    Eur J Neurosci; 2005 Mar; 21(5):1379-84. PubMed ID: 15813947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisense mapping KOR-1: evidence for multiple kappa analgesic mechanisms.
    Pasternak KR; Rossi GC; Zuckerman A; Pasternak GW
    Brain Res; 1999 May; 826(2):289-92. PubMed ID: 10224306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
    J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate.
    Wiley MD; Poveromo LB; Antapasis J; Herrera CM; Bolaños Guzmán CA
    Neuropsychopharmacology; 2009 Apr; 34(5):1339-50. PubMed ID: 18923399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.
    Abraham AD; Casello SM; Land BB; Chavkin C
    Addict Neurosci; 2022 Mar; 1():. PubMed ID: 36176476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV; Patkar KA; McLaughlin JP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18396-401. PubMed ID: 19841255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response.
    Spadoni F; Martella G; Martorana A; Lavaroni F; D'Angelo V; Bernardi G; Stefani A
    Synapse; 2004 Mar; 51(3):194-205. PubMed ID: 14666517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
    Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
    Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
    Martinez D; Slifstein M; Matuskey D; Nabulsi N; Zheng MQ; Lin SF; Ropchan J; Urban N; Grassetti A; Chang D; Salling M; Foltin R; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1720-1727. PubMed ID: 31026862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
    Zhao Y; Joshi AA; Aldrich JV; Murray TF
    Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One-trial cocaine-induced behavioral sensitization in preweanling rats: role of contextual stimuli.
    Herbert MS; Der-Ghazarian T; Palmer AG; McDougall SA
    Exp Clin Psychopharmacol; 2010 Jun; 18(3):284-95. PubMed ID: 20545393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H.
    Logrip ML; Janak PH; Ron D
    Alcohol; 2009 Aug; 43(5):359-65. PubMed ID: 19671462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.
    Bruchas MR; Xu M; Chavkin C
    Neuroreport; 2008 Sep; 19(14):1417-22. PubMed ID: 18766023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.
    Bruchas MR; Land BB; Lemos JC; Chavkin C
    PLoS One; 2009 Dec; 4(12):e8528. PubMed ID: 20052275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
    Shippenberg TS; LeFevour A; Heidbreder C
    J Pharmacol Exp Ther; 1996 Feb; 276(2):545-54. PubMed ID: 8632320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.